Experts are working on the concepts that patients whose reaction to first colonoscopy test is negative they might not have to rely on invasive cancer screening and bypass repeated colonoscopy tests, as published by the magazine- Annals of Internal Medicine.
This change can cost $3 millions in the healthcare industry and reducing risk of medical issues pertaining to screening tests.
Articles:
Section:
News: